The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Current Status of Gadolinium Toxicity in Patients with Kidney Disease
Abstract
Gadolinium-based contrast (GBC) agents have recently been the subject of intense interest for physicians across numerous specialties. These agents are widely used as contrast for magnetic resonance imaging and have been generally considered safe. Early on, phase III trials and small studies in low-risk patients suggested a benign renal profile; however, more recent studies raised the possibility of nephrotoxicity, although it is not clear whether it approaches the incidence of nephropathy associated with iodinated radiocontrast. In 2006, reports of a rare systemic fibrosing condition called nephrogenic systemic fibrosis (NSF) were recently linked to exposure of patients with advanced kidney disease to GBC agents. Analysis of the data suggests that certain GBC agents are more likely to be associated with NSF. Also, not all patients with kidney disease are at risk for developing NSF, only those with advanced acute or chronic kidney disease. Avoidance of GBC exposure is the best approach for high-risk patients. When GBC is required to obtain optimal images, use of low dosages of more stable macrocyclic agents is safer and preferred. This article reviews the current status of GBC agents as nephrotoxins and causes of NSF and provides opinions on how to use these agents in patients with underlying kidney disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ever more evidence is accumulating that gadolinium-based contrast enhancement agents induce nephrogenic systemic fibrosis (NSF) in patients with underlying kidney disease. As a consequence, gadolinium-based contrast agents are contraindicated in patients with impaired renal function [187].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [187]
Citations
Cites
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,862
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,398
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,011
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I. B., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 599
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J. P., Zito, G., & Cowper, S. E. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 542
Nephrogenic Fibrosing Dermopathy
Cowper, S. E., Su, L. D., Bhawan, J., Robin, H. S., & LeBoit, P. E. (2001) · American Journal of Dermatopathology · doi:10.1097/00000372-200110000-00001 · Cited by 473
Nephrotoxicity of high‐dose gadolinium compared with iodinated contrast
Prince, M. R., Arnoldus, C. L., & Frisoli, J. K. (1996) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880060129 · Cited by 401
Gadolinium deposition in nephrogenic fibrosing dermopathy
Boyd, A. S., Zic, J. A., & Abraham, J. L. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 374
Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide
Thomsen, H. S. (2006) · European Radiology · doi:10.1007/s00330-006-0495-8 · Cited by 352
Collidge, T., Thomson, P. C., Mark, P. B., Traynor, J. P., Jardine, A. G., Morris, S., Simpson, K., & Roditi, G. (2007) · Radiology · doi:10.1148/radiol.2451070353 · Cited by 319
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–275 of 275
Emerging nanoparticle-based x-ray imaging contrast agents for breast cancer screening
Mossburg, K. J., Barragan, D., O, N. H., Kian, A. C., Maidment, A. D. A., & Cormode, D. P. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2496129 · Cited by 2
Functionalization of nanodiamonds and their current status in biomedical research
Huang, L., Guo, Y., Li, Z., & Zhang, B. (2026) · Diamond and Related Materials · doi:10.1016/j.diamond.2026.113608 · Cited by 2
Lipiec, P., Płońska‐Gościniak, E., Kuśmierek, J., Płachcińska, A., Stefańczyk, L., Majos, A., Peruga, J. Z., Szymański, P., Kępka, C., & Kasprzak, J. D. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0048 · Cited by 2
Wang, H., Huang, S. D., Young, A., Cramer, S. P., Yoda, Y., & Li, L. (2023) · Physchem · doi:10.3390/physchem4010003 · Cited by 2
Contrast-enhanced dynamic magnetic resonance nephrography in healthy dogs
Fonseca-Matheus, J. M., Pérez-García, C. C., Ginja, M., Altónaga, J. R., Orden, M. A., & Gonzalo-Orden, J. M. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.06.025 · Cited by 2
Goffin, E. J., Schroeder, J. A., Weingart, C., Decleire, P.-Y., & Cosyns, J. P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp664 · Cited by 2
Edwards, N. C., Hayer, M. K., Ferro, C. J., Townend, J., & Steeds, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-56042-7_5 · Cited by 2
Periprocedural Concerns in the Patient with Renal Disease
Payton, P., & Eter, A. (2018) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2018.08.003 · Cited by 2
Rapalino, O., Kamalian, S., Gupta, R., Phan, C. M., Pomerantz, S. R., Romero, J. M., Joshi, M. C., & Lev, M. H. (2010) · Medical radiology · doi:10.1007/174_2010_32 · Cited by 2
Risk of Acute Kidney Injury Following Gadolinium-based Contrast Agent-enhanced MRI
Han, M. W., Kim, P. H., Suh, C. H., Park, K. J., Park, H. J., Lee, C. W., Lee, J. H., & Chung, H. W. (2025) · Investigative Radiology · doi:10.1097/rli.0000000000001239 · Cited by 1
Cardiac Imaging to Assist Complex Ablation Procedures
Restrepo, A., & Dickfeld, T. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_29 · Cited by 1
Echocardiography in Nephrology
Lullo, L. D., Granata, A. R. M., Bàrbera, V., & Bellasi, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-60794-4_26 · Cited by 1
Radermacher, J. (2013) · Der Nephrologe · doi:10.1007/s11560-013-0814-4 · Cited by 1
Imaging Contrast Agents and Pharmacoradiology
Skucas, J. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-5117-4.00001-5 · Cited by 1
Dissolubility of rare-earth metal phosphates in nitric acid
Smirnova, A. G., Цыганкова, М. В., Зимина, Г. В., Nikolaeva, I. I., & JSC “Akron”, V. N. (2015) · Nonferrous Metals · doi:10.17580/tsm.2015.12.10 · Cited by 1
Safety profile of Gadoterate meglumine on the renal function of patients with severe kidney disease
Jawahar, A., Bulbul, J. E., Adams, W., Joyce, C., Yacoub, J. H., & Goldberg, A. (2022) · Clinical Imaging · doi:10.1016/j.clinimag.2022.08.021 · Cited by 1
Zhang, Y., Cao, J., Zhang, Y., Zheng, X., Chen, W., & Wang, Y. (2025) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2025.04.005 · Cited by 1
Toxicité rénale des produits de contraste non iodés
Janus, N., Launay‐Vacher, V., & Deray, G. (2018) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2018.09.002 · Cited by 1
AbuRahma, A. F., & Stone, P. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1326-8_1
ROLE OF LARGE ANIMAL MODELS IN TRANSLATIONAL STUDIES OF IMAGING AND TARGETED DRUG DELIVERY
Uthamanthil, R., & Tian, M. (2013) · Wiley eBooks · doi:10.1002/9781118356845.ch17
48-jährige Patientin mit bekanntem M. Crohn und neu aufgetretener Erythrozyturie sowie Proteinurie
Kündiger, T., Wirths, K., Wegjan, E., & Zöpf, T. (2010) · Der Internist · doi:10.1007/s00108-010-2750-y
Switchable lanthanide fluorescence probes in homogenous molecular diagnostics
Lehmusvuori, A. (2013) · UTUPub (University of Turku)
"Nanotheranostics" for Tumor Imaging and Targeted Drug Delivery.
Zou, P. (2011) · Deep Blue (University of Michigan)
Magnetic Resonance Imaging in ESRD Patients: What are the Options?
Perazella, M. A. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12271
Self-citationL’utilisation du Gadolinium pour les interventions artérielles
Sambol, E. B., der Meer, J. G. V., Graham, A. R., Goldstein, L. J., Karwowski, J., Dayal, R., DeRubertis, B. G., & Kent, K. C. (2011) · Annales de Chirurgie Vasculaire · doi:10.1016/j.acvfr.2012.03.010
What do we really know about contrast-induced nephropathy?
Vurušić, B., & Ostrički, B. (2013) · Cardiologia Croatica · doi:10.15836/ccar.2013.242
The five most cited NDT papers from 2005 to 2009
Lameire, N., Floege, J., & Wheeler, D. C. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq464
Recent therapeutic strategies based on the stage of chronic kidney disease
Kim, Y. H. (2009) · The Korean Journal of Internal Medicine
Gadolinium Induced Acute Kidney Injury and Nephrogenic Systemic Fibrosis
Banday, K. A., Robbani, I., Choh, N. A., Siraj, F., Haque, F. U., Wani, I., & Wani, M. M. (2012) · J Med Sci · doi:10.33883/jms.v15i2.155
Everyday Practice: Diabetes Mellitus MRI contrast media: What clinicians need to know
Das, C. J., Mahalingam, S., Debnath, J., & Dhawan, S. (2010)
Magnetic resonanse in ischaemic heart disease
Gruszczyńska, K., & Baron, J. (2011) · Advances in Interventional Cardiology · doi:10.5114/pwki.2011.21191
The synthesis and application of iron oxide nanoparticles for targeted imaging using MRI
Arora, J. (2016) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27582771
Lipiec, P., Płońska‐Gościniak, E., Walecki, J. M., Kasprzak, D., Kostkiewicz, M., Miszalski−Jamka, T., Szyszka, A., Gackowski, A., Kukulski, T., Skowerski, M., et al. (2013)
Zhu, L. (2015) · Digital Collections of Colorado (Colorado State University)
Statistical Methods for Magnetic Resonance Image Analysis with Applications to Multiple Sclerosis.
Pomann, G. (2015) · NCSU Libraries Repository (North Carolina State University Libraries)
Liu, Y. (2018) · Springer theses · doi:10.1007/978-3-319-74920-4_4
Strontium extraction during complex processing of apatite concentrate
Lozhkina, L. E., Sadykova, M. M., Зимина, Г. В., & Spiridonov, F. M. (2018) · Nonferrous Metals · doi:10.17580/tsm.2018.02.06
Risk Factors and Risk Assessment in Acute Kidney Injury
King, J. D., & Rosner, M. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00016-9
Poitry‐Yamate, C., Vogt, S., Gleber, C., Lepore, M. G., Salome-Pateyron, M., & Rolf Gruetter, A. (2018) · Microscopy and Microanalysis · doi:10.1017/s1431927618014186
Gold - Human Serum Albumin Contrast Agents
Fields, S. K. (2017) · Digital WPI
Kshirsagar, P., Shetty, V. S., Mody, P., & Gawade, H. N. (2018) · International Surgery Journal · doi:10.18203/2349-2902.isj20184620
Improving treatment and imaging in ADPKD
van Gastel, M. D. A. (2019) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Contrast agents in Nephrology – a literature review
Fernandes, S. C., & Ferreira, A. F. (2019) · Portuguese Journal of Nephrology & Hypertension · doi:10.32932/pjnh.2019.10.034
Vandeleene, B., & Leemrijse, T. (2015) · Elsevier eBooks · doi:10.1016/b978-2-294-73893-7.00046-x
Perazella, M. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3362-2.00019-1
Self-citationLe pied diabétique : place de la chirurgie orthopédique
Besse, J., & Leemrijse, T. (2009) · Elsevier eBooks · doi:10.1016/b978-2-84299-909-4.00007-9
Awareness of Gadolinium Toxicity Among Non-radiologists in Saudi Arabia
Sandougah, K. J., AlJohar, R., Aladhadhi, D., Alhazmi, Y., Kariri, M. N., & Abdulrahman, K. A. B. (2022) · Cureus · doi:10.7759/cureus.21104
(2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328334b3e8
(2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283454167
Deb, S., & Patra, H. K. (2015) · Wiley eBooks · doi:10.1002/9781118998922.ch6
Current awareness: Pharmacoepidemiology and drug safety
(2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1651
Cerrahi Yoğun Bakım Hastalarında Kontrast Madde Nefropatisi için Risk Faktörleri
Araz, Ç., Ayas, H. M., Camkıran, A., Pirat, A., Zeyneloğlu, P., & Arslan, G. (2012) · Türk yoğun bakım derneği dergisi/Türk yoğun bakım dergisi · doi:10.4274/tybdd.38
Examens d’imagerie chez le patient insuffisant rénal chronique sévère
Matillon, X. (2022) · Progrès en Urologie - FMC · doi:10.1016/j.fpurol.2022.06.001
Imaging Modalities and Their Applications in Cancer Detection Using Nanomaterials
Rane, G., Patkar, D., & Chaughule, R. (2022) · Springer eBooks · doi:10.1007/978-3-031-09636-5_1
Loginova, T. P., Baranov, O. V., Pozdniakova, N. V., Shtykova, E. V., Ezernitskaya, M. G., Orlov, V. N., Shchetinin, I. V., Kovalev, A. I., Korlyukov, A. A., Talanova, V. N., et al. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06479-9
Cardiac MRI in Diagnosis and Management of HCM
Parwani, P. J., & Chua, A. Y. T. (2025) · Springer eBooks · doi:10.1007/978-3-031-99282-7_9
Damasco, J. A., Ohulchanskyy, T. Y., Mahajan, S., Chen, G., Singh, A., Kutscher, H. L., Huang, H., Turowski, S. G., Spernyak, J. A., Singh, A. K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13725105
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047211
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047217
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047220
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047226
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047214
Batra, A., Barnard, A. M., Lott, D. J., Willcocks, R. J., Forbes, S. C., Chakraborty, S., Daniels, M. J., Arbogast, J., Triplett, W. T., Henricson, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20047223
Chimie de surface de nanocristaux fluorescents pour l’imagerie biologique
Debayle, M. (2019) · theses.fr (ABES) · doi:10.70675/53f29694z9f9bz4211z8456z9b9a7a283af8
Développement d’agents théranostiques IRM multifonctionnels ciblant le cholangiocarcinome
Khan, M. (2024) · theses.fr (ABES) · doi:10.70675/8325aed0z37efz49afzbe91ze20656657597
Polaron activation in conjugated polymers for enhanced T 2 MRI contrast
Song, Y., Lin, Q., & Shao, Z. (2026) · Nanoscale · doi:10.1039/d6nr00661b
Yan, H., Qi, Z., Yang, H., & Su, P. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116487
Liu, Z., Zhao, C., Huang, Z., Guo, F., Wang, D. J. J., & Shao, X. (2026) · Magnetic Resonance in Medicine · doi:10.1002/mrm.70637
Metadata
- Authors
- Perazella, M. A.
- Affiliations
- Yale University (US)
- Corresponding author
- Perazella, Mark A.
- ORCID
- Perazella, Mark A.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-02
- Volume
- 4
- Issue
- 2
- Pages
- 461-469
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2116878814
- Cited by
- 275
- References
- 42
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 17 · 2021: 16 · 2020: 7 · 2019: 21 · 2018: 22 · 2017: 23 · 2016: 12 · 2015: 18 · 2014: 15 · 2013: 17 · 2012: 29
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Nephrology
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- gadolinium-based contrast agents, nephrogenic systemic fibrosis, nephrotoxicity, chronic kidney disease, acute kidney injury, MRI contrast safety
- MeSH terms
- Animals, Contrast Media, Dose-Response Relationship, Drug, Gadolinium, Humans, Kidney Diseases, Magnetic Resonance Imaging, Risk Factors, Risk Assessment, Evidence-Based Medicine, Nephrogenic Fibrosing Dermopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review